237 related articles for article (PubMed ID: 37700218)
1. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration.
Wei L; Niraula D; Gates EDH; Fu J; Luo Y; Nyflot MJ; Bowen SR; El Naqa IM; Cui S
Br J Radiol; 2023 Oct; 96(1150):20230211. PubMed ID: 37660402
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
Prelaj A; Miskovic V; Zanitti M; Trovo F; Genova C; Viscardi G; Rebuzzi SE; Mazzeo L; Provenzano L; Kosta S; Favali M; Spagnoletti A; Castelo-Branco L; Dolezal J; Pearson AT; Lo Russo G; Proto C; Ganzinelli M; Giani C; Ambrosini E; Turajlic S; Au L; Koopman M; Delaloge S; Kather JN; de Braud F; Garassino MC; Pentheroudakis G; Spencer C; Pedrocchi ALG
Ann Oncol; 2024 Jan; 35(1):29-65. PubMed ID: 37879443
[TBL] [Abstract][Full Text] [Related]
4. Multiomics, artificial intelligence, and precision medicine in perinatology.
Pammi M; Aghaeepour N; Neu J
Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
[TBL] [Abstract][Full Text] [Related]
5. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.
Mikdadi D; O'Connell KA; Meacham PJ; Dugan MA; Ojiere MO; Carlson TB; Klenk JA
Cancer Biomark; 2022; 33(2):173-184. PubMed ID: 35213360
[TBL] [Abstract][Full Text] [Related]
6. Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Shrestha R; Llaurado Fernandez M; Dawson A; Hoenisch J; Volik S; Lin YY; Anderson S; Kim H; Haegert AM; Colborne S; Wong NKY; McConeghy B; Bell RH; Brahmbhatt S; Lee CH; DiMattia GE; Le Bihan S; Morin GB; Collins CC; Carey MS
Cancer Res; 2021 Apr; 81(7):1681-1694. PubMed ID: 33441310
[TBL] [Abstract][Full Text] [Related]
7. Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).
Wang Y; Lin W; Zhuang X; Wang X; He Y; Li L; Lyu G
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240090
[TBL] [Abstract][Full Text] [Related]
8. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing.
Li Z; Gu H; Xu X; Tian Y; Huang X; Du Y
Front Immunol; 2023; 14():1288027. PubMed ID: 38022625
[TBL] [Abstract][Full Text] [Related]
10. Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers.
Chen X; Huo XF; Wu Z; Lu JJ
Chin Med Sci J; 2021 Sep; 36(3):196-203. PubMed ID: 34666872
[TBL] [Abstract][Full Text] [Related]
11. A novel subtype to predict prognosis and treatment response with DNA driver methylation-transcription in ovarian cancer.
Xu Z; Zhang L; Wang M; Huang Y; Zhang M; Li S; Wang L; Li K; Hou Y
Epigenomics; 2022 Sep; 14(18):1073-1088. PubMed ID: 36200265
[TBL] [Abstract][Full Text] [Related]
12. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.
Kang W; Qiu X; Luo Y; Luo J; Liu Y; Xi J; Li X; Yang Z
J Transl Med; 2023 Sep; 21(1):598. PubMed ID: 37674169
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome.
Clifford C; Vitkin N; Nersesian S; Reid-Schachter G; Francis JA; Koti M
Am J Reprod Immunol; 2018 Aug; 80(2):e12975. PubMed ID: 29781548
[TBL] [Abstract][Full Text] [Related]
14. The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review.
Parpinel G; Laudani ME; Piovano E; Zola P; Lecuru F
Cancer Control; 2023; 30():10732748231159553. PubMed ID: 36847148
[TBL] [Abstract][Full Text] [Related]
15. Multiomics, virtual reality and artificial intelligence in heart failure.
Gladding PA; Loader S; Smith K; Zarate E; Green S; Villas-Boas S; Shepherd P; Kakadiya P; Hewitt W; Thorstensen E; Keven C; Coe M; Nakisa B; Vuong T; Rastgoo MN; Jüllig M; Starc V; Schlegel TT
Future Cardiol; 2021 Nov; 17(8):1335-1347. PubMed ID: 34008412
[TBL] [Abstract][Full Text] [Related]
16. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
He T; Huang L; Li J; Wang P; Zhang Z
Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
[No Abstract] [Full Text] [Related]
17. Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis.
Zhang Z; Wei Z; Zhao L; Gu C; Meng Y
J Obstet Gynaecol; 2023 Dec; 43(1):2171778. PubMed ID: 36803381
[TBL] [Abstract][Full Text] [Related]
18. Multiomics tools for improved atherosclerotic cardiovascular disease management.
Sopic M; Vilne B; Gerdts E; Trindade F; Uchida S; Khatib S; Wettinger SB; Devaux Y; Magni P;
Trends Mol Med; 2023 Dec; 29(12):983-995. PubMed ID: 37806854
[TBL] [Abstract][Full Text] [Related]
19. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.
Yang B; Li X; Zhang W; Fan J; Zhou Y; Li W; Yin J; Yang X; Guo E; Li X; Fu Y; Liu S; Hu D; Qin X; Dou Y; Xiao R; Lu F; Wang Z; Qin T; Wang W; Zhang Q; Li S; Ma D; Mills GB; Chen G; Sun C
Cell Rep Med; 2022 Dec; 3(12):100856. PubMed ID: 36543113
[TBL] [Abstract][Full Text] [Related]
20. Application of artificial intelligence in the diagnosis and prognostic prediction of ovarian cancer.
Zhou J; Cao W; Wang L; Pan Z; Fu Y
Comput Biol Med; 2022 Jul; 146():105608. PubMed ID: 35584585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
